The wording leaves NWBO the ability to discuss L, but I'd assume on the off chance they had topline results, they would announce those separately and submit their abstract for an upcoming conference. I suppose they could discuss other L data from expanded use, but it seems the presenter, Dr. Bosch, has been working a great deal on DCVax-Direct for phase II, so I'd be surprised if we did not hear more about that.
News 
Market Data 
Discover 
